Nuvation Bio
NUVB
3.80
-0.01
-0.26%
Nuvation Bio
US · NUVB
#2898 by market cap
Listed 1970
3.80
-0.01
-0.26%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
Recent news
-
Rating change
Citi Maintains Nuvation Bio(NUVB.US) With Buy Rating, Maintains Target Price $12Market Newswire · 2026/10/16
-
Rating change
Truist Financial Maintains Nuvation Bio(NUVB.US) With Buy RatingMarket Newswire · 2026/9/15
-
Rating change
Truist Financial Maintains Nuvation Bio(NUVB.US) With Buy Rating, Announces Target Price $13Market Newswire · 2026/8/7
-
Rating change
B. Riley Securities Maintains Nuvation Bio(NUVB.US) With Buy Rating, Raises Target Price to $14Market Newswire · 2026/8/7
-
Rating change
RBC Capital Maintains Nuvation Bio(NUVB.US) With Buy Rating, Cuts Target Price to $19Market Newswire · 2026/7/7
-
Rating change
RBC Capital Maintains Nuvation Bio(NUVB.US) With Buy Rating, Maintains Target Price $19Market Newswire · 2026/7/21
-
Rating change
Cantor Fitzgerald Initiates Nuvation Bio(NUVB.US) With Buy Rating, Announces Target Price $12Market Newswire · 2026/8/21
-
Rating change
H.C. Wainwright Maintains Nuvation Bio(NUVB.US) With Buy Rating, Raises Target Price to $21Market Newswire · 2026/7/27
-
Rating change
Citi Initiates Nuvation Bio(NUVB.US) With Buy Rating, Announces Target Price $12Market Newswire · 2026/9/30
-
Rating change
Wedbush Maintains Nuvation Bio(NUVB.US) With Buy Rating, Maintains Target Price $11Market Newswire · 2026/9/15
-
RBC Capital Maintains Nuvation Bio(NUVB.US) With Buy Rating, Cuts Target Price to $17Market Newswire · 2026/11/5
-
Rating change
RBC Capital Maintains Nuvation Bio(NUVB.US) With Buy Rating, Maintains Target Price $20Market Newswire · 2026/10/14
-
J.P. Morgan Maintains Nuvation Bio(NUVB.US) With Buy Rating, Announces Target Price $11Market Newswire · 2026/11/9
-
Rating change
A Quick Look at Today's Ratings for Nuvation Bio(NUVB.US), With a Forecast Between $12 to $21Market Newswire · 2026/8/7
-
JonesTrading Maintains Nuvation Bio(NUVB.US) With Buy Rating, Maintains Target Price $12Market Newswire · 2026/11/5
-
Rating change
J.P. Morgan Maintains Nuvation Bio(NUVB.US) With Buy RatingMarket Newswire · 2026/9/16
-
Rating change
J.P. Morgan Initiates Nuvation Bio(NUVB.US) With Buy Rating, Announces Target Price $13Market Newswire · 2026/8/18
-
H.C. Wainwright Maintains Nuvation Bio(NUVB.US) With Buy Rating, Maintains Target Price $21Market Newswire · 2026/11/5
-
Rating change
Analysts Offer Insights on Healthcare Companies: AgomAb Therapeutics NV ADR (AGMB), Nuvation Bio (NUVB) and ArriVent BioPharma, Inc. (AVBP)TipRanks · 2026/9/15
-
A Quick Look at Today's Ratings for Nuvation Bio(NUVB.US), With a Forecast Between $11 to $21Market Newswire · 2026/11/6
-
Rating change
H.C. Wainwright Reaffirms Their Buy Rating on Nuvation Bio (NUVB)TipRanks · 2026/5/27
-
Rating change
JonesTrading Maintains Nuvation Bio(NUVB.US) With Buy Rating, Maintains Target Price $12Market Newswire · 2026/7/22
-
Rating change
H.C. Wainwright Maintains Nuvation Bio(NUVB.US) With Buy Rating, Maintains Target Price $21Market Newswire · 2026/7/28
-
Rating change
H.C. Wainwright Maintains Nuvation Bio(NUVB.US) With Buy Rating, Maintains Target Price $17Market Newswire · 2026/5/27
-
Rating change
TD Cowen Maintains Nuvation Bio(NUVB.US) With Buy RatingMarket Newswire · 2026/6/2
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-11-20 19:30:05 · For reference only, not investment advice and not tailored to your situation.
Nuvation Bio discussion 0 comments